TKT and neoplasm: As the treatment time increased, the group receiving JCPyV VLP (encapsulating the tk suicide gene) and the GCV injection (PSAtk-VLPs/GCV) showed a slowing trend in tumor volume increase; by contrast, the tumor volumes in the VLP/GCV and mock groups gradually increased (Fig. 3A, and Suppl.